Related Experiment Video
Updated: Nov 22, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers
Gaurav Pathria1, Ze'ev A Ronai1
1Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Abstract:
Sustained proliferative potential of cancer cells creates heightened energetic and biosynthetic demands. The resulting overt dependence of cancer cells on unperturbed nutrient supply has prompted a widespread interest in amino acid restriction strategies as potential cancer therapeutics. However, owing to rapid signaling and metabolic reprogramming in cancer cells, the prospects for success of amino acid restriction approaches remain unclear. We thus recognize that the identification of co-vulnerabilities of amino acid-restricted cancers may inform actionable targets for effective combined interventions. In this perspective, we outline the current state of key cellular mechanisms underlying adaptation to amino acid restriction and discuss the role of signal transduction pathways governing cancer cell resistance to amino acid restriction, with potential ramifications for the design of future therapeutic efforts.
Insights
Cancer cells
Area of Science:
- Oncology
- Cancer Biology
- Metabolic Pathways
Background:
- Cancer cells exhibit high proliferation rates, increasing their need for nutrients.
- This nutrient dependence makes amino acid restriction a potential therapeutic strategy.
- However, cancer cells can reprogram signaling and metabolism, complicating this approach.
Purpose of the Study:
- To explore co-vulnerabilities in amino acid-restricted cancers.
- To identify actionable targets for combined cancer interventions.
- To review cellular adaptation mechanisms and signaling pathways in cancer resistance to amino acid restriction.
Main Methods:
- Literature review and synthesis of current research.
- Analysis of cellular mechanisms of adaptation to nutrient stress.
- Discussion of signal transduction pathways involved in cancer cell resistance.
Main Results:
- Cancer cells' high demand for nutrients creates vulnerabilities.
- Signaling and metabolic reprogramming enable cancer cell resistance to amino acid restriction.
- Understanding these mechanisms is key to developing effective therapies.
Conclusions:
- Targeting co-vulnerabilities alongside amino acid restriction may enhance therapeutic efficacy.
- Further research into adaptive mechanisms is crucial for designing novel cancer treatments.
- This perspective informs future therapeutic strategies for nutrient-dependent cancers.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

